Anita Balazs
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Clade 2.3.4.4b H5N1 influenza A virus exhibits high infectivity in human respiratory tract models.
Journal: The Journal of infection
Published: February 25, 2026
Reflection confocal microscopy for quantitative assessment of airway surface layer dysregulation and pharmacological rescue in cystic fibrosis under near-physiological conditions.
Journal: Scientific reports
Published: September 17, 2025
Human induced pluripotent stem cells for in vitro modeling of impaired mucociliary clearance in cystic fibrosis lung disease.
Journal: Stem cell research & therapy
Published: July 22, 2025
Don't forget the mucus barrier in pulmonary drug delivery!
Journal: The Journal of physiology
Published: March 19, 2025
Lung tissue-optimized gene editing in human cystic fibrosis models following topical application of lipid nanoparticles.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 07, 2025
The potentiator ivacaftor is essential for pharmacological restoration of F508del-CFTR function and mucociliary clearance in cystic fibrosis.
Journal: JCI insight
Published: October 10, 2024
SARS-CoV-2 Infection of Human Lung Air-Liquid Interface Cultures Reveals Basal Cells as Relevant Targets.
Journal: The Journal of infectious diseases
Published: July 23, 2024
A cell-permeable nanobody to restore F508del cystic fibrosis transmembrane conductance regulator activity.
Journal: Nature chemical biology
Published: May 17, 2024
Personalized CFTR Modulator Therapy for G85E and N1303K Homozygous Patients with Cystic Fibrosis.
Journal: International journal of molecular sciences
Published: June 21, 2023
RECAST: Study protocol for an observational study for the understanding of the increased REsilience of Children compared to Adults in SARS-CoV-2 infecTion.
Journal: BMJ open
Published: April 17, 2023
Last Updated: 09/26/2026